Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-99-002901
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
17
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 HALSEY DRUG CO., INC. 10-K 197262
2 CERTIFICATE OF INCORPORATION AND AMENDMENTS EX-3.1 5881
3 AMENDED AND RESTATED BY-LAWS EX-3.3 26013
4 A/R AND CONSOLIDATED BRIDGE LOAN AGREEMENT EX-10.45 154148
5 1ST AMENDMENT TO A/R CONSOLIDATED BRIDGE L. AGREE EX-10.46 33014
6 2ND AMENDMENT TO A/R CONSOLIDATED BRIDGE L. AGREE EX-10.47 32661
7 FORM OF 10% CONVERTIBLE SECURED NOTE EX-10.48 30547
8 FORM OF COMMON STOCK PURCHASE WARRANT EX-10.49 32943
9 AMENDED AND RESTATED GENERAL SECURITY AGREEMENT EX-10.50 54741
10 SUBORDINATION AGREEMENT EX-10.51 25881
11 AGENCY LETTER AGREEMENT EX-10.52 13639
12 LEASE AGREEMENT EX-10.53 138807
13 LEASE AGREEMENT EX-10.54 40371
14 MANUFACTURING AND SUPPLY AGREEMENT EX-10.55 53363
15 1998 STOCK OPTION PLAN EX-10.56 33814
16 CONSENT OF GRANT THORNTON LLP EX-23.1 662
17 FINANCIAL DATA SCHEDULE EX-27 2057
  Complete submission text file 0000950123-99-002901.txt   878987
Mailing Address 695 N. PERRYVILLE ROAD ROCKFORD IL 61107
Business Address 1827 PACIFIC ST BROOKLYN NY 11233 7184677500
HALSEY DRUG CO INC/NEW (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 99583826
SIC: 2834 Pharmaceutical Preparations